In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.

Published: 07-May-2013

Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.

Published: 12-Nov-2012

CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.

Published: 25-Oct-2012

Catalent says making its technology available to industry will not affect its competitive edge.

Published: 22-Oct-2012

Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow.

Published: 17-Oct-2012

The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July  will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer.

Published: 21-Aug-2012

Negotiating funding for drugs with local health authorities prior to commercialisation is the key to success for biopharmas working in the changing European market, says Quintiles.

Published: 07-Jun-2012

The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co.

Published: 31-May-2012

Including home visits in clinical trial designs could be the key to patient retention, according to ResearchNurses.co.

Published: 30-May-2012

‘CROs: look at the entire portfolio, not just the individual project, when planning clinical studies,’ says DIA’s adaptive design scientific working group.

Published: 22-May-2012

SGS has added formulation development to its service offering through the expansion of its laboratory in Illinois.

Published: 07-May-2012

The European CMO industry could be blocked by over complex layers of regulation, says Frost & Sullivan analyst Aiswariya Chidambaram.

Published: 25-Apr-2012

Designing trials around patients’ habits is the key to success in patient compliance, according to online recruitment specialist Rebar Interactive.

Published: 16-Apr-2012

Those seeking leadership positions in the pharmaceutical world should take to social networking sites to get noticed, recruitment specialists say.

Published: 10-Apr-2012

Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark.

Published: 05-Apr-2012

Catalent wants to build on its European expansions by replicating the end-to-end drug development services model in emerging markets. 

Published: 04-Apr-2012

Sourcing comparator drugs for trials is a complex ‘art’ that requires knowledge of trading, regional regulations and an awareness of drugmakers’ competitive concerns according to Clinigen Group CEO Peter George.

Published: 27-Mar-2012

Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant.

Published: 26-Mar-2012

The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.

Published: 15-Mar-2012

Pharma companies must become more involved in building patient communities through social media if they want to see a successful trial recruitment process according to Patient Nucleus founder Jamie Blackburn.

Published: 27-Feb-2012

Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.

Published: 25-Jan-2012

Sponsor and CRO perceptions of the quality of outsourced service provision differ markedly according to a study by consulting and survey research organisation, the Avoca Group.

Published: 08-Dec-2011

The global contract manufacturing market may be showing signs of recovery but careful investment and focusing on core activities is still the most sensible approach according to Sweden-based CDMO Recipharm.

Published: 05-Dec-2011

Contract services providers which embed service personnel in pharma companies are becoming more prominent in the industry.

Published: 21-Nov-2011

Almac says growing demand for non-GMP manufacturing work rather than competition was the key driver for expansion of its product development services business.

Published: 15-Nov-2011